Hepatitis C: a critical analysis of therapeutic response predictors
Treatment of chronic hepatitis C is still unspecific. However, there is great expectancy concerning the new pegylated interferons. As there has been much controversy about the best parameters to determine whether treatment is effective, we analyzed several criteria currently used for evaluation, including serum alanine aminotransferase (ALT) normalization, viral load reduction and improvement of hepatic histology.
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Brazilian Society of Infectious Diseases
2002
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000200003 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1413-86702002000200003 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1413-867020020002000032003-03-25Hepatitis C: a critical analysis of therapeutic response predictorsFocaccia,R.Siciliano,R.F.Santos,E.D.B.Boccardo,E.Conceição,O.J.G.Barbosa,U.O.Galante,V.C. ALT normalization hepatitis C viral load reduction Treatment of chronic hepatitis C is still unspecific. However, there is great expectancy concerning the new pegylated interferons. As there has been much controversy about the best parameters to determine whether treatment is effective, we analyzed several criteria currently used for evaluation, including serum alanine aminotransferase (ALT) normalization, viral load reduction and improvement of hepatic histology.info:eu-repo/semantics/openAccessBrazilian Society of Infectious DiseasesBrazilian Journal of Infectious Diseases v.6 n.2 20022002-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000200003en10.1590/S1413-86702002000200003 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Focaccia,R. Siciliano,R.F. Santos,E.D.B. Boccardo,E. Conceição,O.J.G. Barbosa,U.O. Galante,V.C. |
spellingShingle |
Focaccia,R. Siciliano,R.F. Santos,E.D.B. Boccardo,E. Conceição,O.J.G. Barbosa,U.O. Galante,V.C. Hepatitis C: a critical analysis of therapeutic response predictors |
author_facet |
Focaccia,R. Siciliano,R.F. Santos,E.D.B. Boccardo,E. Conceição,O.J.G. Barbosa,U.O. Galante,V.C. |
author_sort |
Focaccia,R. |
title |
Hepatitis C: a critical analysis of therapeutic response predictors |
title_short |
Hepatitis C: a critical analysis of therapeutic response predictors |
title_full |
Hepatitis C: a critical analysis of therapeutic response predictors |
title_fullStr |
Hepatitis C: a critical analysis of therapeutic response predictors |
title_full_unstemmed |
Hepatitis C: a critical analysis of therapeutic response predictors |
title_sort |
hepatitis c: a critical analysis of therapeutic response predictors |
description |
Treatment of chronic hepatitis C is still unspecific. However, there is great expectancy concerning the new pegylated interferons. As there has been much controversy about the best parameters to determine whether treatment is effective, we analyzed several criteria currently used for evaluation, including serum alanine aminotransferase (ALT) normalization, viral load reduction and improvement of hepatic histology. |
publisher |
Brazilian Society of Infectious Diseases |
publishDate |
2002 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702002000200003 |
work_keys_str_mv |
AT focacciar hepatitiscacriticalanalysisoftherapeuticresponsepredictors AT sicilianorf hepatitiscacriticalanalysisoftherapeuticresponsepredictors AT santosedb hepatitiscacriticalanalysisoftherapeuticresponsepredictors AT boccardoe hepatitiscacriticalanalysisoftherapeuticresponsepredictors AT conceicaoojg hepatitiscacriticalanalysisoftherapeuticresponsepredictors AT barbosauo hepatitiscacriticalanalysisoftherapeuticresponsepredictors AT galantevc hepatitiscacriticalanalysisoftherapeuticresponsepredictors |
_version_ |
1756416298828431360 |